GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu(Chinese Academy of Sciences), C.H. Arrowsmith(University Health Network), Benjamin Haibe‐Kains(University of Toronto), Seyed Ali Madani Tonekaboni(University Health Network), Jennifer Cruickshank(Ontario Institute for Cancer Research), Jillian Haight(University Health Network), Susan J. Done(University Health Network), Lan-Xin Zhang(University of Toronto), Ravi N. Vellanki(University Health Network), Shili Duan(Ontario Institute for Cancer Research), Bradly G. Wouters(Princess Margaret Cancer Centre), Evelyne Lima‐Fernandes(University of Toronto), Nergiz Doğan(University Health Network), Wail Ba-Alawi(King Abdullah University of Science and Technology), Michelle Kushida(Hospital for Sick Children), Hellen Kuasne(McGill University Health Centre), Stanley Zhou(University Health Network), David W. Cescon(Princess Margaret Hospital), Peter B. Dirks(Hospital for Sick Children), Panagiotis Prinos(University of Toronto), Anne-Marie Fortier(McGill University Health Centre), Hassan Mahmoud(University Health Network), Geneviève Deblois(Institute for Research in Immunology and Cancer), Morag Park(McGill University Health Centre), Trevor D. McKee(University Health Network), Wenjun Chen(University of Toronto), Sarina Cameron(University Health Network), Yan Nie(University Health Network), Mathieu Lupien(Ontario Institute for Cancer Research)
Cited by 307
Related Papers
Epigenetic protein families: a new frontier for drug discovery
|Nature Reviews Drug Discovery|2012|1.3k
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
|Cell stem cell|2009|1.1k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867